HANNAH HETZEL: Open Payments
NPI 1295002038 · BUTLER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$952 in 54 payments from 16 companies in 2025. Trend: 2023 $573 · 2024 $481 · 2025 $952
Food & beverage: $895Education: $57
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 19 | $202 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $90 |
| Regeneron Healthcare Solutions, Inc. | 4 | $86 |
| AstraZeneca Pharmaceuticals LP | 4 | $78 |
| Merck Sharp & Dohme LLC | 3 | $62 |
| Amgen Inc. | 3 | $61 |
| SANOFI-AVENTIS U.S. LLC | 1 | $57 |
| Verona Pharma, Inc. | 3 | $57 |
| Lilly USA, LLC | 2 | $42 |
| Insmed, Inc. | 2 | $41 |
Products named: DUPIXENT, NUCALA, WINREVAIR, TEZSPIRE, TRELEGY ELLIPTA, BREZTRI, Ohtuvayre, OFEV.
Industry payments across PA — which companies pay providers there.
